SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000895345-22-000827
Filing Date
2022-12-19
Accepted
2022-12-19 16:10:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 ff-1614699_13g-satter.htm SC 13G 57370
  Complete submission text file 0000895345-22-000827.txt   58631
Mailing Address C/O SATTER INVESTMENT MANAGEMENT, LLC 676 NORTH MICHIGAN AVENUE, SUITE 4000 CHICAGO IL 60611
Business Address
Satter Muneer A (Filed by) CIK: 0001315797 (see all company filings)

Type: SC 13G

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Subject) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88058 | Film No.: 221471171
SIC: 2834 Pharmaceutical Preparations